What is Novavax's interest expense?

Novavax (NVAX) reported interest expense of $4.9M in Q1 2026.

How has Novavax's interest expense changed year-over-year?

Novavax's interest expense decreased by 14.4% year-over-year, from $5.72M to $4.9M.

What is the long-term trend for Novavax's interest expense?

Over 4 years (2021 to 2025), Novavax's interest expense has grown at a 1.6% compound annual growth rate (CAGR), from $21.13M to $22.55M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Novavax NVAX Interest Expense

Interest Expense at other companies

Viridian Therapeutics, Inc.VRDN

$3.46M+529%

ALN

Alnylam PharmaceuticalsALNY

$69.29M+18.8%

Gilead SciencesGILD

$240M-7.7%

ImmunityBio, Inc.IBRX

$13.87M+2.5%

BioCryst PharmaceuticalsBCRX

$19.78M-15.8%

Mirum Pharmaceuticals, Inc.MIRM

$3.62M+0.6%

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's interest expense?: Novavax (NVAX) reported interest expense of $4.9M in Q1 2026.
How has Novavax's interest expense changed year-over-year?: Novavax's interest expense decreased by 14.4% year-over-year, from $5.72M to $4.9M.
What is the long-term trend for Novavax's interest expense?: Over 4 years (2021 to 2025), Novavax's interest expense has grown at a 1.6% compound annual growth rate (CAGR), from $21.13M to $22.55M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.